Bausch Health Companies | VRX - Trade Debtors



Bausch Health Companies reported $2.21B in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Amgen USD 8.7B 569M Jun/2025
ANI Pharmaceuticals USD 225.65M 5.32M Jun/2025
Aurora Cannabis CAD 39.14M 10.38M Jun/2025
Bausch Health Companies USD 2.21B 138M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Canopy Growth CAD 50.03M 972K Jun/2025
Corcept Therapeutics USD 64.57M 2.75M Jun/2025
Danaher USD 4.52B 202M Jun/2025
Drreddys Laboratories INR 115.44B 3.95B Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
Novo Nordisk 90.28B 3.92B Jun/2025
Pacira USD 114.37M 9.62M Jun/2025
Perrigo USD 678.2M 38.6M Jun/2025
Prestige Brands USD 168.4M 25.89M Jun/2025
Supernus Pharmaceuticals USD 140.83M 4.81M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025
Zoetis USD 1.54B 179M Jun/2025